Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States by J. Bradley Layton, Lauren Peetluk, Hui Lee Wong, Yixin Jiao, Djeneba Audrey Djibo, Christine Bui, Patricia C. Lloyd, Joann F. Gruber, Michael Miller, Rachel P. Ogilvie, Jie Deng, Ron Parambi, Jennifer Song, Lisa B. Weatherby, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, John D. Seeger, Grace Wenya Yang, Dóra Illei, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Kandace L. Amend, Mary S. Anthony, Azadeh Shoaibi

“…Individuals with a complete primary series but without a booster/additional dose were one-to-one matched to boosted individuals on calendar date, geography, and clinical factors. COVID-19 diagnoses were identified in any medical setting, or specifically in hospitals/emergency departments (EDs). …”
Get full text